A NOVEL CELL LINE FOR STUDYING DOPAMINE D2 AND SEROTONIN 5-HT2A HETERODIMERIZATION

被引：0
|
作者：
Gomez Fernandez, S. [1 ]
Lopez-Gimenez, J. F. [2 ]
Varela, M. J. [1 ]
Marcia-Rivas, M. D. [1 ]
Cadavid, M., I [1 ]
Brea, J. [1 ]
Loza, M., I [1 ]
机构：
[1] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Santiago De Compostela, A Coruna, Spain
[2] CSIC, UC, Inst Biomed & Biotechnol Cantabria IBBTEC, Santander, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2015年 / 117卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
C084
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [41] Paliperidone -: Antipsychotic agent, treatment of bipolar disorder, dual dopamine D2/5-HT2A receptor antagonist
    Revill, P.
    Serradell, N.
    Bolos, J.
    DRUGS OF THE FUTURE, 2006, 31 (07) : 579 - 584
  • [42] Proof of Concept Study for Designed Multiple Ligands Targeting the Dopamine D2, Serotonin 5-HT2A, and Muscarinic M1 Acetylcholine Receptors
    Szabo, Monika
    Lim, Herman D.
    Herenbrink, Carmen Klein
    Christopoulos, Arthur
    Lane, J. Robert
    Capuano, Ben
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (03) : 1550 - 1555
  • [43] Potentiation of neurite outgrowth by brexpiprazole, a novel serotonin-dopamine activity modulator: A role for serotonin 5-HT1A and 5-HT2A receptors
    Ishima, Tamaki
    Futannura, Takashi
    Ohgi, Yuta
    Yoshimi, Noriko
    Kikuchi, Tetsuro
    Hashimoto, Kenji
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 (04) : 505 - 511
  • [44] Effects of antipsychotics with diverse dopamine D2 and serotonin 5-HT1A properties on cerebral dopamine and serotonin levels in rats
    Assié, M
    Ravailhe, V
    Faucillon, V
    Newman-Tancredi, A
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S438 - S438
  • [45] Combined serotonin (5-HT)1A agonism, 5-HT2A and dopamine D2 receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats
    Oyamada, Yoshihiro
    Horiguchi, Masakuni
    Rajagopal, Lakshmi
    Miyauchi, Masanori
    Meltzer, Herbert Y.
    BEHAVIOURAL BRAIN RESEARCH, 2015, 285 : 165 - 175
  • [46] Discovery of Bishomo(hetero)arylpiperazines as Novel Multifunctional Ligands Targeting Dopamine D3 and Serotonin 5-HT1A and 5-HT2A Receptors
    Butini, Stefania
    Campiani, Giuseppe
    Franceschini, Silvia
    Trotta, Francesco
    Kumar, Vinod
    Guarino, Egeria
    Borrelli, Giuseppe
    Fiorini, Isabella
    Novellino, Ettore
    Fattorusso, Caterina
    Persico, Marco
    Orteca, Nausicaa
    Sandager-Nielsen, Karin
    Jacobsen, Thomas Amos
    Madsen, Kim
    Scheel-Kruger, Jorgen
    Gemma, Sandra
    JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (12) : 4803 - 4807
  • [47] Chronic administration of clozapine increases the level of serotonin 5-HT1A receptor heterodimerisation with 5-HT2A or D2 receptors in the mouse cortex
    Szlachta, M.
    Faron-Gorecka, A.
    Kusmider, M.
    Pabian, P.
    Kolasa, M.
    Solich, J.
    Zurawek, D.
    Dziedzicka-Wasylewska, M.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2018, 28 : S7 - S8
  • [48] Novel, flexible, and conformationally defined analogs of gepirone:: synthesis and 5-HT1A,5-HT2A, and D2 receptor activity
    Paluchowska, MH
    Bugno, R
    Bojarski, AJ
    Charakchieva-Minol, S
    Duszynska, B
    Tatarczynska, E
    Klodzinska, A
    Stachowicz, K
    Chojnacka-Wójcik, E
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (04) : 1195 - 1200
  • [49] Bifeprunox: a novel antipsychotic agent with partial agonist properties at dopamine D2 and serotonin 5-HT1A receptors
    Wadenberg, Marie-Louise G.
    FUTURE NEUROLOGY, 2007, 2 (02) : 153 - 165
  • [50] Z,-338, a novel gastroprokinetic agent with no effect on dopamine D2 nd serotonin 5-HT4 receptors
    Ueki, S
    Matsunaga, Y
    Yoshida, K
    Yoneta, T
    Kurimoto, T
    Itoh, Z
    GASTROENTEROLOGY, 1999, 116 (04) : A1094 - A1094
12345